Cambridge, MA, United States of America

Simon Delagrave


 

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Stoneham, MA (US) (2012 - 2019)
  • Camridge, MA (US) (2019)
  • Cambridge, MA (US) (2016 - 2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Simon Delagrave

Introduction

Simon Delagrave is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biotechnology. With a total of 13 patents to his name, Delagrave has made remarkable advancements in the development of herpesvirus compositions and related methods. His work has the potential to impact therapeutic approaches in virology.

Latest Patents

Delagrave's latest patents include innovative compositions for herpesvirus and methods for their preparation. One notable patent focuses on liquid and dried compositions comprising a live, attenuated, or genetically modified herpesvirus. This composition includes at least two pharmaceutically acceptable excipients, one of which is histidine and another being a sugar or sugar alcohol. These compositions are designed to retain a high infectious titre following storage or large-scale manufacturing processes, such as lyophilization. Another significant patent involves an ICP0-mediated enhanced expression system, which outlines methods and compositions for increasing the production of recombinant proteins by introducing ICP0 to cells capable of producing these proteins.

Career Highlights

Throughout his career, Simon Delagrave has worked with notable organizations, including Sanofi Pasteur Biologics, LLC and Sanofi Pasteur Inc. His experience in these companies has allowed him to contribute to groundbreaking research and development in the field of biopharmaceuticals.

Collaborations

Delagrave has collaborated with esteemed colleagues such as Sophia Mundle and Stephen F Anderson. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Simon Delagrave's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in therapeutic methods for viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…